How Colombia's biosimilar regulation departs from international norms.

How Colombia's biosimilar regulation departs from international norms. Rev Panam Salud Publica. 2018 Feb 19;41:e78 Authors: Lietzan E PMID: 29466527 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/29466527?dopt=Abstract

Source: Pan American Journal of Public Health - February 24, 2018 Category: International Medicine & Public Health Tags: Rev Panam Salud Publica Source Type: research

More News: Colombia Health | International Medicine & Public Health